chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe arm pain; This case was reported by a physician via sales rep and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The reporter stated that, the patient had severe arm pain after shingrix injection. The reporter consented to follow up. This case is 1 of the 2 linked cases, reported by the same reporter.
Patient stated he had blurred vision day after vaccine, symptoms were starting to clear up but patient was unsure if they were related to the vaccine, however they did start 1-2 days after the vaccine
On the 9th day after receiving Dose 1 of the Moderna mRNA vaccine shot, I had a ring in my left ear followed by a sting much like a bee sting. The ring was like a phone ring.
Pt received vaccine on 5-9-14. She called on 5-11 complaining of redness and swelling in the area around the where the vaccine was given. Recommended calling family physician on Monday to see if treatment is needed.
This spontaneous report as received from a field representative via a pharmacist refers to a patient of unknown age and gender who was also a pharmacy technician. The patient's medical history and concurrent medications were not reported. On an unspecified date, the patient was vaccinated with a dose of ZOSTAVAX (dose and route not provided) (lot # J001004, expired date 24-APR-2014). Concomitant therapy was not reported. On an unspecified date the patient developed redness at the injection site. The patient did not seek medical attention. At the time of the report the outcome of the event was unknown. The relationship between event redness at the injection site and ZOSTAVAX was not reported. Additional information has been requested.
Felt tingling in arm thru shoulder & tingling & tightness in th. She drank some water which helped slightly. Paramedics Arrived, bpa little high but pt said it's normal for her. Had her Mom dri e home when she said she didn't want to go to the hospital.
patient was given an expired dose on 06/28/2022, COVID vaccine expired on 06/30/2022. patient reported no symptoms
PATIENT CAME IN FOR A BIVALENT DOSE AND WAS INADVERTANTLY GIVEN A MONOVALENT DOSE. ERROR WAS REPORTED TO VAERS AND PATIENT WAS ADVISED TO WAIT TWO MONTHS AND RETURN FOR THE BIVALENT DOSE.
Within days of receiving Pfizer COVID-19 booster on December 20, 2021 m, my blood pressure - which had been previously high to hypertensive stage 1, increased rapidly resulting in arm radiating pain and pain in back of neck, upper back and chest, breathlessness, and extreme fatigue even after initial booster symptoms abated. Purchased upper arm cuff blood pressure device on 12/31 and BP was 194/110 BPM 69; was treated at ER and placed on low dose medication- 5 mg amlodipine but was not controlled - clinicians throughout weekend via telemedicine increased to 10 mg amlodipine, added losartan and increased eventually up to 100 mg losartan; nonetheless had to return to ER Monday because 5 am reading 191/104 BPM 64. After seeing cardiologist also prescribed Hydrochlorothiazide 12.5 mg. Significant diet changes made (less than 2000 mg sodium, no caffeine, dash diet) and BP (particularly diastolic) continues to read at least once a day stage 1 and stage 2 hypertensive even after nearly month on three new medications
This spontaneous report was received from a physician via a company representative and refers to a patient of unknown age and gender. The patient's concurrent conditions included a renal transplant, that was performed "recently" (date unknown) that required a chronic unspecified immunosuppressant therapy. On an unknown date, the patient was vaccinated with ZOSTAVAX (dose, route, lot # and expiry date were not reported) for prophylaxis; that was received along with sterile diluent (MERCK) (dose, route, lot # and expiry date were not reported). No adverse effect reported. No product quality complaint (PQC) involved.
I had visual disturbance (shiny vision in left visual field) for about 45 minutes the morning of 1/25/21.  I went to primary care and also had an appointment with Medical Center for an eye evaluation.  They diagnosed me with an ocular migraine.  I have never had an ocular migraine or any form of visual disturbance or migraine previously.
Headache after booster; Fatigue after booster; Rash on  face, arm and chest after booster; Sore left arm after booster; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on  face, arm and chest after booster), MYALGIA (Sore left arm after booster), HEADACHE (Headache after booster) and FATIGUE (Fatigue after booster) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Oct-2021, the patient experienced MYALGIA (Sore left arm after booster). On 30-Oct-2021, the patient experienced RASH (Rash on  face, arm and chest after booster). On 02-Nov-2021, the patient experienced HEADACHE (Headache after booster) and FATIGUE (Fatigue after booster). On 30-Oct-2021, MYALGIA (Sore left arm after booster) had resolved. At the time of the report, RASH (Rash on  face, arm and chest after booster), HEADACHE (Headache after booster) and FATIGUE (Fatigue after booster) outcome was unknown.            No concomitant medications was provided by the reporter. No treatment was provided by the reporter.   This case was linked to MOD-2021-372412, MOD-2021-372307 (Patient Link).
Vaccine administered on 8/18/18. Patient first reported on 8/21/18. On 8/18/18 patient had a injection site mild rash. Patient then reported on 8/26/18. Injection site rash did not improve. Dark red about 1 inch diameter. Not tender to touch, not a raised bump, not warm to touch. Painful only sometime.
FEELING HOT AND COLD; SLUGGISHNESS; FLU LIKE SYMPTOMS; SORENESS AT INJECTION SITE; This spontaneous report received from a patient concerned a 55 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced feeling hot and cold. On APR-2021, the subject experienced sluggishness. On APR-2021, the subject experienced flu like symptoms. On APR-2021, the subject experienced soreness at injection site. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms on APR-2021, had not recovered from soreness at injection site, and the outcome of feeling hot and cold and sluggishness was not reported. This report was non-serious.
10/4/12 - Received FLUARIX Rt. deltoid. 10/5/12 - Rt. deltoid swollen, painful, warm to touch. 10/6/12 - Increased swelling, redness, pain. 10/6/12 - Eval by nurse practitioner at local pharmacy. 10/8/12 - Eval by employer designated MD provider. Symptoms resolving. Rt. deltoid Arthus Rxn.
Slurred speech, tongue tremor, circumoral numbness, dysphagia, drooling,  30 lb weight loss
Headache, blood clot and was operated twice.  Subdural Hemotoma.
Pregnant 20 weeks currently; I experienced left arm soreness at the injection site with a stinging sensation to half of my face.  These symptoms lasted four days then they resolved.
Menstrual cycle changes.  After 17 years of a light 3 to 5 day cycle my periods are at 6 to 8 days of extremely heavy bleeding with clots. Very painful cramping. Very painful shooting/ stabbing pains in my breasts the week leading up to and during my cycle. The bleeding is so bad it affected my anemia, which is hard enough to treat. This months cycle has been the worst yet. I'm bleeding very heavily and weak due to this.
This spontaneous report was received from a nurse and medical assistant referring to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On approximately 18-OCT-2017 (reported as "around"), the patients were vaccinated with improperly stored doses of ROTATEQ with lot # M044399, expiration date 25-JUN-2018 (route, dose, dose number, frequency and anatomical location were unknown) for prophylaxis. There was no adverse effect reported. The medical assistant reported that administered doses of vaccines experienced the temperature excursion of 32°F to 35°F (35F) degrees Fahrenheit for 24 hours and the nurse reported a temperature excursion of 35°F degrees Fahrenheit for 24 hours. On the other hand, a previous temperature excursion of 35°F degrees Fahrenheit for 36 hours was also reported. There was no data logger involved.
Wheeze, dry cough, slight stuffy nose, itchy throat, started to start at around 9:00 PM. Able to sleep through the night did not take any medications. 10-22-07 PC to client. Did not see HCP. Nasal congestion and itchy throat continued throughout weekend. Also allergic to cats, sulfa, shellfish and environmental allergies. Reports symptoms similar to cat allergies. Reports call to HCP - the RN feel not related to imm. No exposure to known allergens.
Severe chills Fever Dizziness Confusion Temporary loss of vision- lasted approximately 10 minutes following a dizzy spell. Complete loss of vision in both eyes. Happened about 15 hours post vaccination in the middle of the night.  Severe enough we almost called 911
the back of her neck hurts and when she turns her head from side to side; pain goes down her spine which is a sharp pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 47 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Oct2021 09:00 (Lot number: FC3184) at the age of 47 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Date: 10Sep2021, Time: 10-11 am, Anatomical location: left arm , Lot: FC3184, No NDC , Expiry: known.), administration date: 10Sep2021, when the patient was 47 years old, for Covid-19 immunization. The following information was reported: NECK PAIN (non-serious) with onset 03Oct2021, outcome "not recovered", described as "the back of her neck hurts and when she turns her head from side to side"; SPINAL PAIN (non-serious) with onset 03Oct2021, outcome "not recovered", described as "pain goes down her spine which is a sharp pain". Therapeutic measures were taken as a result of neck pain, spinal pain.  No follow-up attempts are possible. No further information is expected.
Low grade fever; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), HEADACHE (Headache) and PYREXIA (Low grade fever) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (NO MEDICAL HISTORY REPORTED).    On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced FATIGUE (Fatigue) and HEADACHE (Headache). On 05-Apr-2021, the patient experienced PYREXIA (Low grade fever). At the time of the report, FATIGUE (Fatigue), HEADACHE (Headache) and PYREXIA (Low grade fever) outcome was unknown. Related          Treatment included Tylenol.
I was 9 weeks postpartum at the time of my first vaccination, exclusively breastfeeding and told by my OBGYN not to expect a menstrual cycle for quite a while, maybe a year or more depending on how long breastfeeding continued.  Two days after my vaccine I started my period and have had second one since then.
No further information is available.; Nurse is reporting that today a patient received PROQUAD that was reconstituted with V AQTA due to human error; Nurse is reporting that today a patient received PROQUAD that was reconstituted with VAQTA due to human error; This spontaneous report was received from a registered nurse referring to a 4-year-old male patient. The patient's pertinent medical history, concomitant therapies, previous drug reactions, or allergies were not reported.     On 16-AUG-2021, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHa)(PROQUAD) (dose, route of administration, vaccine scheme and anatomical location were not provided; lot number T035410 has been verified to be a valid lot number, expiration date reported and established as 14-ABR-2022), as prophylaxis, and that was reconstituted with Hepatitis A Vaccine, Inactivated (VAQTA) due to a human error, 0.5 milliliters (ml) (route of administration, vaccine scheme and anatomical location were not provided; lot number T022333 has been verified to be a valid lot number and expiration date reported and established as 11-DEC-2021) as prophylaxis (product preparation error and wrong product administered). No further information is available (no adverse event).
LINEAR ERYTHEMATOUS EXCORIATIONS LEFT LOWER QUADRANT  ERYTHEMATOUS PAPULES AND HIVES  RIGHT UPPER CHEST
c/o being lethargic & dizzy for 48 hrs following administration of vax;
Vaccs 3-18-11 developed rash on legs that spread to buttocks & abdomen over the weekend per mom. Reports child in no distress, afebrile, no scratching. When questioning mom, states "come to think of it she had a light rash on legs at 2mo & 4 mo vacc x 1-2 days" - Mom had not previously reported.
Large Swollen lymph nodes above collar bone; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 26Apr2021 at 11:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history was not provided. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the arm left on 05Apr2021 at 11:45 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. On 27Apr2021 at 05:00 the patient experienced large swollen lymph nodes above collar bone. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event Large Swollen lymph nodes above collar bone was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected
Developed tinnitus in left ear and visited Primary Care physician. MRI of head/brain done with no abnormalities detected. Saw ENT provider, who detected no significant hearing loss inconsistent with aging. Treating with Lipoflavanoids and white noise for sleep.
This spontaneous report was received from a medical assistance, concerning a 4 year old female patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 07-JUL-2017, the patient was vaccinated with an expired dose of MMRII lot number L024268 and expiration date of 01-JUL-2017 for prophylaxis (dose and route of administration were not reported). reconstituted with sterile diluent (lot number and expiration date were not reported) No adverse effects were reported.; Sender's Comments: CL-009507513-1707USA006497:
Dizzy; Feeling off balance; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), BALANCE DISORDER (Feeling off balance) and NAUSEA (Nausea) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.   No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced DIZZINESS (Dizzy), BALANCE DISORDER (Feeling off balance) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizzy), BALANCE DISORDER (Feeling off balance) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Adverse side effects include: diarrhea, stomach pain, discomfort, cranky behavior, problems with sleep, excessive crying, but no fever. The adverse effects came next day after administration of the second dose of Rotateq vaccine. The first dose of Rotateq gave no adverse effects. Rotateq was the only vaccine given to the child. The child was not sick, no fever, no teething. The adverse effects were present for one day.
Started with fussiness about 2 days before she started with bloody stools. She made apt for our office. Dr sent them to medical center. They diagnosed with intussusception. They performed air barium which resolved the intussusception.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 20-JUN-2012, the patient was vaccinated with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 12-FEB-2012 (date discrepancy), the patient was treated by a physician for the onset of a blistering vesicular outbreak, which was diagnosed as severe herpes zoster, or shingles. The patient has been prescribed VALTREX for management of her persistent painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Approx 12 hours after injection, injection site pain on left shoulder began to increase, as well as flu like muscle pain and fever.  By very early A.M the next day, general body ache was intense (like severe flu, perhaps Mono), injection site pain had spread to entire arm, could not lift.   Fever peaked at 101F. Neither ibruprofen nor Tylenol did anything for the pain. Was severe enough it was impossible to sleep.   By the end of the 2nd day (evening) most symptoms had reduced considerably except for mild pain, sore arm. Fever broke.   3rd day, mild 99.8 fever returned as well as muscle aches.   As of this time, 7 days later, moderate muscle aches, mild fever keep coming and going.  Currently have no fever, but still very worn out feeling, moderate muscle aches.  Injection still slightly tender at times.  This is my 3rd Moderna injection, booster.   Side effects have increased with each shot.
loose stools; cold sweats; This spontaneous case was reported by a nurse and describes the occurrence of DIARRHOEA (loose stools) and COLD SWEAT (cold sweats) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced DIARRHOEA (loose stools) and COLD SWEAT (cold sweats). At the time of the report, DIARRHOEA (loose stools) and COLD SWEAT (cold sweats) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment information provided.
indication=Treatment of COVID-19; indication=Treatment of COVID-19; This is a spontaneous report received from a contactable reporter (Other Health Professional) from product quality group. The reporter is the patient.  A 63 year-old female patient (not pregnant) received bnt162b2 (Pfizer-BioNTech COVID-19), administered in arm left, administration date 03Jan2022 (Lot number: FL3197) at the age of 62 years as dose 3 (booster), single, administered in arm left, administration date 03Jul2021 (Lot number: EW0180) as dose 2, single and administered in arm left, administration date 12Jun2021 (Lot number: EW0182) as dose 1, single for covid-19 immunisation. Relevant medical history included: "parathyroid disease (removal of diseased parathyroid 2015)" (unspecified if ongoing); "Bicuspid Aortic Valve" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing); "removal of diseased parathyroid", start date: 2015 (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE, start date: 05Feb2021; CHELATED MAGNESIUM [MAGNESIUM CHELATE]; QUERCETIN; OMEGA-3 FATTY ACIDS; ESTER-C [ASCORBIC ACID]; DIM DETOX; COQ10 [UBIDECARENONE]; SAW PALMETTO [SERENOA REPENS]; METHYL B COMPLEX; DHEA; VIT D3; PREGNENOLONE; BERGAMOT BPF; Pure Genomics Multivitamin; Stamets 7. No known allergies The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "indication=Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive, notes: Indication: Treatment of COVID-19. Therapeutic measures were taken as a result of covid-19. Treatment with PAXLOVID(Treatment start date: Mar2022, Lot number: FX2740); Sender's Comments: Based on limited information in the case , a possible causal association between  the reported  events Vaccination failure, covid 19 and the suspect drug BNT162B2 cannot be excluded.
Cough  New loss of taste or smell  Congestion or running nose  Recommended plenty of fluids.  OTC treatment for symptoms.